Serina Therapeutics, Inc.
SER
$2.57
$0.072.80%
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 19.29% | -5.94% | |||
| Gross Profit | -19.29% | 5.94% | |||
| SG&A Expenses | -3.67% | 9.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.03% | 1.18% | |||
| Operating Income | -8.03% | -1.18% | |||
| Income Before Tax | 7.76% | -107.69% | |||
| Income Tax Expenses | -- | -61.11% | |||
| Earnings from Continuing Operations | 7.86% | -106.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.86% | -106.77% | |||
| EBIT | -8.03% | -1.18% | |||
| EBITDA | -8.05% | -1.28% | |||
| EPS Basic | 5.32% | -82.01% | |||
| Normalized Basic EPS | 11.44% | -40.72% | |||
| EPS Diluted | 5.32% | -81.38% | |||
| Normalized Diluted EPS | 11.44% | -40.72% | |||
| Average Basic Shares Outstanding | 36.01% | 12.97% | |||
| Average Diluted Shares Outstanding | 36.01% | 12.97% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||